Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Infection & Inflammation

Menampilkan semua 9 hasil

products_default

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Baca selengkapnya

products_default

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Baca selengkapnya

products_default

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Baca selengkapnya

products_default

Critically Ill COVID-19 Infected Patients Exhibit Increased Clot Waveform Analysis Parameters Consistent with Hypercoagulability.

Baca selengkapnya

products_default

Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19.

Baca selengkapnya

products_default

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

Baca selengkapnya

products_default

Management of COVID‐19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory

Baca selengkapnya

products_default

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.

Baca selengkapnya

products_default

Temporal Changes in Immune Blood Cell Parameters in COVID‐19 Infection and Recovery from Severe Infection

Baca selengkapnya

X

You are redirected to a 3rd party website!

Clicking on a social media link implies that you understand you are leaving our site and entering a third-party website. We are not responsible for their content, privacy policies, or terms of use. Please review their terms and privacy policy before proceeding. We do not endorse or control the third-party website and disclaim any liability for damages or consequences.